These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32569387)

  • 1. Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from authors.
    Galván-Casas C; Catalá A; Carretero Hernández G; Garcia-Doval I
    Br J Dermatol; 2020 Oct; 183(4):789. PubMed ID: 32569387
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 infection: the same virus can cause different cutaneous manifestations.
    Drago F; Ciccarese G; Rebora A; Muzic SI; Parodi A
    Br J Dermatol; 2020 Oct; 183(4):788. PubMed ID: 32533844
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?
    Ghazal S; Litvinov IV; Aljahani N; Jfri A; Netchiporouk E
    J Cutan Med Surg; 2020; 24(4):416-417. PubMed ID: 32391713
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on 'Cutaneous manifestations in COVID-19: a first perspective' by Recalcati S.
    Hedou M; Carsuzaa F; Chary E; Hainaut E; Cazenave-Roblot F; Masson Regnault M
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e299-e300. PubMed ID: 32314436
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous manifestations in COVID-19: a first perspective.
    Recalcati S
    J Eur Acad Dermatol Venereol; 2020 May; 34(5):e212-e213. PubMed ID: 32215952
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous manifestations of COVID-19: A review of the published literature.
    Elmas ÖF; Demirbaş A; Özyurt K; Atasoy M; Türsen Ü
    Dermatol Ther; 2020 Jul; 33(4):e13696. PubMed ID: 32458546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic values of cutaneous manifestations in COVID-19.
    Suchonwanit P; Leerunyakul K; Kositkuljorn C
    Dermatol Ther; 2020 Jul; 33(4):e13650. PubMed ID: 32445279
    [No Abstract]   [Full Text] [Related]  

  • 8. [Are there cutaneous manifestations of SARS-CoV-2?].
    Drerup KA; Gläser R
    Hautarzt; 2020 Sep; 71(9):734-736. PubMed ID: 32778924
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: SARS-CoV-2 induced gastrointestinal inflammation-authors' reply.
    Taxonera C; Alba C
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1750-1751. PubMed ID: 33205880
    [No Abstract]   [Full Text] [Related]  

  • 10. Invisible spread of SARS-CoV-2 - Authors' reply.
    Kucharski AJ; Eggo RM
    Lancet Infect Dis; 2020 Sep; 20(9):1012. PubMed ID: 32275870
    [No Abstract]   [Full Text] [Related]  

  • 11. Authors' Reply.
    Farkash EA; Wilson AM; Jentzen JM
    J Am Soc Nephrol; 2020 Sep; 31(9):2225-2226. PubMed ID: 32792369
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 infection in conjunctival tissue - Authors' reply.
    Hui KP; Peiris M; Nicholls JM; Chan MC
    Lancet Respir Med; 2020 Jul; 8(7):e58. PubMed ID: 32649922
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymorphic cutaneous manifestations of COVID-19 infection in a single viral host.
    Patel N; Kho J; Smith KE; Ahmed A; Van den Abbeele K; Mandal AKJ; Missouris CG
    Int J Dermatol; 2020 Sep; 59(9):1149-1150. PubMed ID: 32686096
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous manifestation of COVID-19 in images: a case report.
    Avellana Moreno R; Estela Villa LM; Avellana Moreno V; Estela Villa C; Moreno Aparicio MA; Avellana Fontanella JA
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e307-e309. PubMed ID: 32330339
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend? Authors' reply.
    Pei L; Zhang S; Geng X; Li W; Chen D
    Pol Arch Intern Med; 2020 Oct; 130(10):922-923. PubMed ID: 33119226
    [No Abstract]   [Full Text] [Related]  

  • 16. CT screening for early diagnosis of SARS-CoV-2 infection - Authors' reply.
    Shi H; Han X; Cao Y; Alwalid O; Zheng C
    Lancet Infect Dis; 2020 Sep; 20(9):1011. PubMed ID: 32222163
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era.
    Mastrolonardo M; Romita P; Bonifazi E; Giuffrida R; Lotti T; Foti C; Bonamonte D
    Dermatol Ther; 2020 Jul; 33(4):e13617. PubMed ID: 32424886
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to: Correspondence relating to "SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19".
    Wang Y; Lu F; Zhao J
    J Hepatol; 2020 Oct; 73(4):996-998. PubMed ID: 32589896
    [No Abstract]   [Full Text] [Related]  

  • 19. Did Whatsapp
    Duong TA; Velter C; Rybojad M; Comte C; Bagot M; Sulimovic L; Bouaziz JD
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e348-e350. PubMed ID: 32330322
    [No Abstract]   [Full Text] [Related]  

  • 20. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.
    Hughes M; Rogers S; Lepri G; Bruni C; Matucci-Cerinic M
    Br J Dermatol; 2020 Sep; 183(3):596-598. PubMed ID: 32460349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.